Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multi-metastatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05567601
What this trial is testing

Doxil/Caelyx BE Study

Who this might be right for
Ovarian CancerAIDS-related Kaposi SarcomaMultiple Myeloma+1 more
Baxter Healthcare Corporation 36
Early research (Phase 1)UnknownNCT05276609
What this trial is testing

ARTEMIS-001: Phase 1 Study of the HS-20093 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Shanghai Hansoh Biomedical Co., Ltd 177
Very early researchLooking for participantsNCT06398457
What this trial is testing

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Who this might be right for
Hematologic MalignancyBone Marrow Transplant RejectionAcute Myeloid Leukemia (AML)+9 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Early research (Phase 1)Study completedNCT00573495
What this trial is testing

Multipeptide Vaccine for Advanced Breast Cancer

Who this might be right for
Breast NeoplasmBreast CancerCancer of the Breast+1 more
University of Pennsylvania 11
Testing effectiveness (Phase 2)Study completedNCT03321630
What this trial is testing

A Phase II a Study of Lenvatinib, a Multi-targeted Tyrosine Kinase Inhibitor, Combined With Pembrolizumab (PD-1 Inhibitor) for the Treatment of Metastatic Gastroesophageal Cancer Patients Who Have Progressed on First or Subsequent Line Therapies

Who this might be right for
GastroEsophageal CancerGastric Cancer
NYU Langone Health 24
Testing effectiveness (Phase 2)Study completedNCT00003907
What this trial is testing

Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver

Who this might be right for
Liver CancerMetastatic Cancer
Eastern Cooperative Oncology Group 50
Testing effectiveness (Phase 2)Study completedNCT01514877
What this trial is testing

Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerMetastatic Cancer
Zhejiang Cancer Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT04792489
What this trial is testing

DALY II USA/ MB-CART2019.1 for DLBCL

Who this might be right for
Refractory Diffuse Large B Cell Lymphoma (DLBCL)Relapsed Diffuse Large B Cell LymphomaHigh Grade B-cell Lymphoma (HGBCL)+6 more
Miltenyi Biomedicine GmbH 315
Testing effectiveness (Phase 2)Looking for participantsNCT06154291
What this trial is testing

FIH XON7 in Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Cancer
Xenothera SAS 255
Large-scale testing (Phase 3)Study completedNCT00219258
What this trial is testing

Efficacy and Safety of Zoledronic Acid in Patients With Bone Metastases of Any Solid Tumors or Multiple Myeloma

Who this might be right for
Treatment of Bone Metastases
Novartis 240
Large-scale testing (Phase 3)Study completedNCT00403065
What this trial is testing

Dexamethasone and Supportive Care With or Without Whole-Brain Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer That Has Spread to the Brain and Cannot Be Removed By Surgery

Who this might be right for
Lung CancerMetastatic Cancer
Medical Research Council 1,000
Testing effectiveness (Phase 2)Study completedNCT00087958
What this trial is testing

Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment

Who this might be right for
Breast Cancer
Sanofi 168
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07437625
What this trial is testing

Lesion-Allocated Therapy for Multiple Metastases and Tumor-Zoned Treatment for Bulky Tumors: A Phase II Study of Iodine-125 Seed Implantation Combined With Cryoablation in High-Burden Metastatic Disease

Who this might be right for
High-Burden Metastatic Solid Tumors
Li Min 90
Testing effectiveness (Phase 2)Study completedNCT04405349
What this trial is testing

Investigating the Combination of VB10.16 and Atezolizumab in Patients With HPV 16-positive Cervical Cancer

Who this might be right for
Cervical CancerCervix Cancer
Nykode Therapeutics ASA 52
Not applicableLooking for participantsNCT06230666
What this trial is testing

Single-isocenter SBRT vs. Multiple-isocenter SBRT for Multiple Extracranial Metastases

Who this might be right for
Metastatic Cancer
Matthias Guckenberger 62
Early research (Phase 1)Looking for participantsNCT07369505
What this trial is testing

Sapu003 in Advanced mTOR-sensitive Solid Tumors

Who this might be right for
Breast Cancer MetastaticRenal Cell Carcinoma (RCC)Neuroendocrine Tumors+2 more
SAPU NANO (US) LLC 27
Early research (Phase 1)Study completedNCT00364754
What this trial is testing

Pharmacokinetic Study of Tesmilifene (YMB1002) Plus Epirubicin and Cyclophosphamide in Metastatic Breast Cancer

Who this might be right for
Metastatic/Recurrent Breast Cancer
YM BioSciences 28
Large-scale testing (Phase 3)Study completedNCT02563054
What this trial is testing

Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Hoffmann-La Roche 316
Testing effectiveness (Phase 2)Study completedNCT03136627
What this trial is testing

Phase 1/2 Study of Tivozanib in Combination With Nivolumab in Subjects With RCC

Who this might be right for
Carcinoma, Renal Cell
AVEO Pharmaceuticals, Inc. 28
Testing effectiveness (Phase 2)Study completedNCT00005854
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Fred Hutchinson Cancer Center
Next Page